Induced Myelosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study Groups

• Published in: Blood Vol. 132; no. Supplement 1; p. 5106
• Main Authors: Pleimes, Dirk, Möbus, Volker, Mayer, Frank, Schmidt, Marcus, Asang, Corinna, Flunkert, Kathrin, Mikus, Gerd
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 29.11.2018

Introduction Despite much progress in the treatment of patients with malignant disorders, severe neutropenia and infections are frequent adverse events associated with standard chemotherapy regimens. Due to the low frequency of neutrophil monitoring in most clinical studies, limited insights exist a...